ID   HSC 536 FANCC
AC   CVCL_E3YF
SY   FA-C+C
RX   PubMed=14754601;
CC   Sequence variation: Mutation; HGNC; HGNC:3584; FANCC; Simple; p.Leu554Pro (c.1661T>C); ClinVar=VCV000012043; Zygosity=Unspecified (Coriell=GM13020).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3584; FANCC.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125704; Fanconi anemia, complementation group C
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_G045 ! HSC 536
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
RX   PubMed=14754601;
RA   Clarke A.A., Gibson F.M., Scott J., Myatt N.E., Rutherford T.R.;
RT   "Fanconi's anemia cell lines show distinct mechanisms of cell death in
RT   response to mitomycin C or agonistic anti-Fas antibodies.";
RL   Haematologica 89:11-20(2004).
//